8-K 1 form8-k_17634.htm FORM 8-K DATED MARCH 17, 2014 form8-k_17634.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC  20549


FORM 8-K
 

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):    March 17, 2014
 

 
CAS MEDICAL SYSTEMS, INC.
(Exact name of Registrant as specified in its charter)


Delaware
(State or other jurisdiction
of incorporation)
0-13839
(Commission
File Number)
06-1123096
(I.R.S. Employer
Identification No.)
 
44 East Industrial Road, Branford, Connecticut 06405
(Address of principal executive offices, including zip code)
 
(203) 488-6056
(Registrant's telephone number, including area code)
  
 
  

 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 
 
 
 
Item 3.01.
NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD; TRANSFER OF LISTING.
 
On March 17, 2014, CAS Medical Systems, Inc. (“CASMED” or the "Company") announced that its voluntary request to transfer its common stock listing to the NASDAQ Capital Market from the NASDAQ Global Market has been approved by the Listing Qualifications department of The NASDAQ Stock Market ("NASDAQ").

The Company’s common stock will begin trading under its same ticker – CASM - on the NASDAQ Capital Market effective at the opening of trading on Tuesday, March 18, 2014.

The transfer of CASMED’s common stock listing to the NASDAQ Capital Market is not expected to have any impact on trading in its common stock.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
- 2 -
 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
  CAS MEDICAL SYSTEMS,  INC.  
       
       
       
Date:   March 17, 2014
 By:     /s/ Jeffery A. Baird  
   
Jeffery A. Baird
  
   
Chief Financial Officer
  
       

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
- 3 -